Meyka AI API is live for developers.Start building.
Advertisement
Anika Therapeutics, Inc.

Anika Therapeutics, Inc. (ANIK) Stock Overview

Explore Anika Therapeutics, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ANIK●NASDAQ
HealthcareMedical - Devices
$14.48
$0.31(2.10%)
U.S. Market opens in 56h 12m
Advertisement

Anika Therapeutics, Inc. (ANIK)

Meyka AI Score

Z

Key Financials

Market Cap192.7M
P/E Ratio-17.75
EPS (TTM)$-0.79
ROE-0.08%
Fundamental Analysis

AI Price Forecasts

1 Month$10.77
3 Months$12.26
1 Year Target$0.00

ANIK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Anika Therapeutics, Inc. (ANIK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 45.80, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -17.75 and a market capitalization of 192.7M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.10%
5-Day Change
-2.49%
1-Month Change
-3.14%
3-Month Change
1.61%
6-Month Change
50.83%
Year-to-Date (YTD) Change
50.68%
1-Year Change
29.40%
3-Year Change
-45.83%
5-Year Change
-68.59%
All-Time (Max) Change
313.71%

Contact Information

https://www.anikatherapeutics.com
781 457 9000
32 Wiggins Avenue, Bedford, MA, 01730

Company Facts

288 Employees
IPO DateMay 3, 1993
CountryUS
Actively Trading

Frequently Asked Questions